paper presented by gsk's developing countries operating unit
DESCRIPTION
Presentation by GSK's Developing Countries Operating Unit made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.TRANSCRIPT
Developing Countries Operating Unit
1st Euro-Africa Health Investment Conference: MediPharm, March 26-27, London
Craig WilliamsDirector, Vaccines and Disease of the Developing World
The DC operating unit
Established in August 2010 - to increase patient access to GSK medicines and vaccines while expanding its presence and helping it build a sustainable business in developing countries
Tasked with bringing a dedicated GSK focus to expanding access to medicines for around 800 million people in the world’s least developed countries (LDCs)
The Markets Covers 50 countries, 49 defined by UN as least developed, over half of whom survive on less than $1 a day
currently supply medicines to 37 of the 49 LDCs and employ 650 people across the unit.
GSK’s operating model in Developing Countries
Lower price/higher volume
Volume incentive
Longer-term return on investment
Patented medicines & vaccines capped
at 25% of UK price
20% of profit reinvested in healthcare
infrastructure in country)
The target is a five-fold growth in
volume of medicines & vaccines supplied
to these countries by 2015.
Strategy
1. Vaccines
2. Product Registration/Portfolio Expansion
3. Healthcare Infrastructure
4. People
Vaccines- GAVI
Vaccines: For over 20 years we have made our entire vaccine portfolio available for expanded immunisation programmes at preferential prices to developing countries using a tiered pricing system.
GAVI Pledging Meeting – 13 June 2011
– Initial target : $3.7 billion
–Donors commitment : $4.3 billion
–Resources available for 2011-2015 : $7.6 billion
Health Infrastructure -Our commitment to reinvest 20% of profits
GSK partner with AMREF, CARE International and Save The Children to strengthen healthcare infrastructure in LDCs
To increase the numbers of trained healthcare workers in rural and marginalised communities
A sustainable model to improve healthcare infrastructure in developing countries
Supporting community healthcare workers increases access to medicines and ultimately improves health outcomes
Health Infrastructure - One Family Health
Nurse run Franchise clinic network
Currently 80 clinics in Kenya serving
500,000 patients per year
GSK announced expansion for Rwanda
in April to establish 250 health posts
over the next three years
Health Infrastructure – Anti counterfeiting Nigeria
Using SMS text technology to guarantee the quality of products
GSK added a scratch off panel on the packs to include a unique code. Patients would then text in the code (free) to a central number to authenticate the product.
R&DR&D New Business ModelsNew Business Models Health Systems
Health Systems
• R&D PPPs• WIPO Research• Open lab• Malaria screen• HIV• TB, malaria• Trust in Science (LATAM &
AFRICA)
• Tiered pricing• ViiV Healthcare• DCMA unit• CME• Voluntary licensing• Portfolio
• Branded generics• Small pack sizes• EMAP R&D
• Techonolgy transfer• Brazil JV
• Innovative pricing• Malaria • AMC
• 20% reinvestment• LF elimination• African malaria
Partnership• PHASE• Positive Action and PAFC• Humanitarian relief• De-worming programme
Access to Medicines Contributions
GSK retained ATM leadership in 2012